MTS Medication Technologies, Inc. 

(Public, NASDAQ:MTSI)   Watch this stock   
Find more results for MTSI
Nov 16, 2009
Q2 2010 MTS Medication Technologies Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2009
Net profit margin -0.19% 3.25%
Operating margin 1.50% 5.37%
EBITD margin - 8.79%
Return on average assets -0.42% 7.05%
Return on average equity -0.90% 18.39%
Employees 271 -

Address

2003 Gandy Boulevard North Suite 800
St. Petersburg, FL 33702
United States - Map
+1-727-5766311 (Phone)
+1-727-5731100 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

MTS Medication Technologies, Inc. discussions

  View all discussions »

Description

MTS Medication Technologies, Inc. (MTS) is a holding company that operates through its subsidiaries, MTS Packaging Systems, Inc. (MTSP), MTS Medication Technologies, Ltd. (MTS Limited) and MTS Medication Technologies GmbH (MTS GmbH). MTS GmbH is a wholly owned subsidiary of MTS Limited. MTS primarily manufactures and sells consumable medication punch cards, packaging equipment and ancillary products throughout the United States, Canada and Europe. The Company’s customers are institutional pharmacies that supply nursing homes, assisted living and correctional facilities with prescription medications for their patients.

Officers and directors

Todd E. Siegel
Chairman of the Board, President, Chief Executive Officer
Age: 51
Bio & Compensation - Reuters
John D. Stanton
Vice Chairman of the Board
Age: 60
Bio & Compensation - Reuters
Michael P. Conroy
Chief Financial Officer, Vice President, Corporate Secretary
Age: 61
Bio & Compensation - Reuters
Michael D. Stevenson
Chief Operating Officer, Vice President
Age: 46
Bio & Compensation - Reuters
Perry W. Larson
Vice President - Sales and Marketing
Age: 51
Bio & Compensation - Reuters
James Michael Conroy
Controller
Age: 38
Bio & Compensation - Reuters
Peter A. Williams
Managing Director of MTS Medication Technologies, Ltd.
Age: 48
Bio & Compensation - Reuters
David W. Kazarian
Director
Age: 67
Bio & Compensation - Reuters
Allen S. Braswell Jr.
Director
Age: 51
Bio & Compensation - Reuters
Irv I. Cohen
Director
Age: 58
Bio & Compensation - Reuters